MedPath

Liafensine

Generic Name
Liafensine
Drug Type
Small Molecule
Chemical Formula
C24H22N4
CAS Number
1198790-53-2
Unique Ingredient Identifier
R34ID086Z6

Overview

Liafensine is under investigation in clinical trial NCT00892840 (Multiple-Ascending Dose Study).

Background

Liafensine is under investigation in clinical trial NCT00892840 (Multiple-Ascending Dose Study).

Indication

No indication information available.

Associated Conditions

No associated conditions information available.

FDA Approved Products

No FDA products found for this drug

Singapore Approved Products

No Singapore products found for this drug

Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

© Copyright 2025. All Rights Reserved by MedPath